Facebook to remove anti-vaccine content

US – Facebook will begin taking down posts spreading anti-vaccine conspiracy theories that have been debunked by public health experts.

Covid_vaccine_crop

In a blog post by Kang-Xing Jin, head of health at Facebook, the company confirmed it would work to stop the spread of misinformation about vaccines undermining Covid-19 vaccination programmes.

This includes any false claims about the safety, efficacy, ingredients and side-effects of the vaccines, Facebook said.

Facebook’s decision follows the announcement of several viable Covid-19 vaccines, with the UK having already authorised the use of the Pfizer/BioNTech vaccine, with a vaccination programme due to start next week.

The social media giant has in recent weeks announced several policies to combat the spread of misinformation through its platforms, having already issued restrictions on political advertising in the wake of last month’s US presidential election.

“We will remove false claims that Covid-19 vaccines contain microchips, or anything else that isn’t on the official vaccine ingredient list,” the blog post says.

“We will also remove conspiracy theories about Covid-19 vaccines that we know today are false: like specific populations are being used without their consent to test the vaccine’s safety.

“Since it’s early and facts about Covid-19 vaccines will continue to evolve, we will regularly update the claims we remove based on guidance from public health authorities as they learn more.”

The company said it would not be able to do this “overnight”, and did not provide a date for when it would start removing anti-vaccine content.

We hope you enjoyed this article.
Research Live is published by MRS.

The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.

Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.

For example, there's an archive of winning case studies from over a decade of MRS Awards.

Find out more about the benefits of joining MRS here.

0 Comments


Display name

Email

Join the discussion

Newsletter
Stay connected with the latest insights and trends...
Sign Up
Latest From MRS

Our latest training courses

Our new 2025 training programme is now launched as part of the development offered within the MRS Global Insight Academy

See all training

Specialist conferences

Our one-day conferences cover topics including CX and UX, Semiotics, B2B, Finance, AI and Leaders' Forums.

See all conferences

MRS reports on AI

MRS has published a three-part series on how generative AI is impacting the research sector, including synthetic respondents and challenges to adoption.

See the reports

Progress faster...
with MRS 
membership

Mentoring

CPD/recognition

Webinars

Codeline

Discounts